RESUMEN
Preliminary studies suggested that age at onset (AAO) may help to define homogeneous bipolar affective disorder (BPAD) subtypes. This candidate symptom approach might be useful to identify vulnerability genes. Thus, the probability of detecting major disease-causing genes might be increased by focusing on families with early-onset BPAD type I probands. This study was conducted as part of the European Collaborative Study of Early Onset BPAD (France, Germany, Ireland, Scotland, Switzerland, England, Slovenia). We performed a genome-wide search with 384 microsatellite markers using non-parametric linkage analysis in 87 sib-pairs ascertained through an early-onset BPAD type I proband (AAO of 21 years or below). Non-parametric multipoint analysis suggested eight regions of linkage with P-values<0.01 (2p21, 2q14.3, 3p14, 5q33, 7q36, 10q23, 16q23 and 20p12). The 3p14 region showed the most significant linkage (genome-wide P-value estimated over 10 000 simulated replicates of 0.015 [0.01-0.02]). After genome-wide search analysis, we performed additional linkage analyses with increased marker density using markers in four regions suggestive for linkage and having an information contents lower than 75% (3p14, 10q23, 16q23 and 20p12). For these regions, the information content improved by about 10%. In chromosome 3, the non-parametric linkage score increased from 3.51 to 3.83. This study is the first to use early-onset bipolar type I probands in an attempt to increase sample homogeneity. These preliminary findings require confirmation in independent panels of families.
Asunto(s)
Trastorno Bipolar/genética , Cromosomas Humanos Par 3/genética , Cromosomas Humanos/genética , Genoma Humano , Adolescente , Adulto , Edad de Inicio , Trastorno Bipolar/clasificación , Trastorno Bipolar/epidemiología , Niño , Mapeo Cromosómico , Europa (Continente) , Femenino , Impresión Genómica/genética , Humanos , Escala de Lod , Masculino , Repeticiones de Microsatélite , Fenotipo , Estadísticas no ParamétricasAsunto(s)
Trastorno Bipolar/genética , Proteínas de Ciclo Celular/genética , Cromosomas Humanos Par 6/genética , Proteínas Nucleares/genética , Receptores Acoplados a Proteínas G/genética , Adulto , Trastorno Bipolar/epidemiología , Estudios de Casos y Controles , Europa (Continente)/epidemiología , Haplotipos , Humanos , Desequilibrio de Ligamiento/genética , Linaje , Polimorfismo de Nucleótido Simple/genéticaRESUMEN
A recent study has suggested that the brain-expressed genes for G72 and D-amino-acid oxidase (DAAO) exert an influence on susceptibility to schizophrenia. Our aim was to replicate this finding in German schizophrenic patients and to assess whether G72 and DAAO might also contribute to the development of bipolar affective disorder. We genotyped seven single-nucleotide polymorphisms (SNPs) in the G72 gene and three in the DAAO gene in 599 patients (299 schizophrenic, 300 bipolar) and 300 controls. At G72, individual SNPs and a four-marker haplotype were associated with schizophrenia. The most significant SNP as well as the haplotype were also associated with bipolar affective disorder (BPAD). DAAO was associated with schizophrenia, but not with BPAD. The association of variation at G72 with schizophrenia as well as BPAD provides molecular support for the hypothesis that these two major psychiatric disorders share some of their etiologic background.
Asunto(s)
Trastorno Bipolar/genética , Proteínas Portadoras/genética , D-Aminoácido Oxidasa/genética , Esquizofrenia/genética , Adulto , Trastorno Bipolar/epidemiología , Femenino , Predisposición Genética a la Enfermedad/epidemiología , Haplotipos , Humanos , Péptidos y Proteínas de Señalización Intracelular , Masculino , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple , Factores de Riesgo , Esquizofrenia/epidemiologíaAsunto(s)
Antidepresivos/uso terapéutico , Trastorno Depresivo/genética , Moclobemida/uso terapéutico , Inhibidores de la Monoaminooxidasa/uso terapéutico , Monoaminooxidasa/genética , Polimorfismo Genético , Regiones Promotoras Genéticas , Adulto , Anciano , Alelos , Trastorno Depresivo/tratamiento farmacológico , Trastorno Depresivo/enzimología , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
During the last years, the validity of classic case control studies in psychiatric genetic research has been increasingly under question due to the risk of population stratification problems inherent to this type of association study. By consequence, the application of family-based association studies using parent-offspring trios has been strongly advocated. Recently, however, in a study comparing clinical characteristics between index patients from parent-offspring trios and singleton patients with bipolar affective disorder, the question was raised whether a systematic neglect of case control association studies could lead to a selection bias of susceptibility genes. In a similar approach, we compared demographic and clinical characteristics of 122 singleton bipolar patients with those of 54 bipolar patients derived from parent-offspring trios. The singleton patients did not only present with a higher age of onset, but also with a higher frequency of suicidal behavior and a higher familial loading for suicidality. These findings suggest that the genetic mechanism for disease might be different between trio-based and classic case control samples, where patients are examined whose parents are not available for genetic studies. Thus, giving up case control designs for the sake of family-based association studies could be at the risk of selecting against several genetically determined factors.
Asunto(s)
Trastorno Bipolar/genética , Adulto , Edad de Inicio , Trastorno Bipolar/psicología , Familia , Salud de la Familia , Femenino , Humanos , Entrevistas como Asunto , Masculino , Persona de Mediana Edad , Sesgo de Selección , Intento de Suicidio/estadística & datos numéricosRESUMEN
Various polymorphisms of the X-chromosomal monoamine oxidase A (MAO-A) gene were investigated for association with affective disorders. However, none of the studied variants could consistently be associated with either major depressive or bipolar affective disorder. Recently, a positive association between panic disorder and a novel functional repeat polymorphism in the MAO-A gene promoter, with the longer alleles being more active, was reported. Since monoaminergic neurotransmission is supposed to play an important role in affective disorders, we investigated a potential association of this polymorphism with major depressive illness in a sample of 146 unrelated patients of German descent and a control group of 101 individuals with a negative life history for affective disorders. Similarly to the recent findings in panic disorder, we observed a significantly increased frequency of genotypes containing only long alleles in female patients with recurrent major depression in comparison with age- and sex-matched controls. Thus, our data suggest that an excess of high-activity MAO-A gene promoter alleles resulting in an elevated MAO-A activity is a risk factor for major depressive disorder in females. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96:801-803, 2000.